These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Strategy for developing a safe and cost-effective H2-receptor antagonist program.
    Author: Quercia RA, Chow MS, Jay GT, Quintiliani R.
    Journal: Hosp Formul; 1991 Nov; 26 Suppl D():20-4. PubMed ID: 10136561.
    Abstract:
    The pharmacy staff of a community tertiary-care hospital evaluated efficacy and safety before addressing cost considerations in the transition to a capitation program with cimetidine as the preferred H2-receptor antagonist. Safety concerns were resolved by permitting the use of an alternative drug certain patients considered to be at high risk. Despite initial resistance to mandatory participation in the program, the physician and nursing staffs have grown supportive, and the annual cost savings, which include the costs of labor and supplies as well as acquisition, have been substantial.
    [Abstract] [Full Text] [Related] [New Search]